Singapore markets open in 7 hours 35 minutes

Pfizer Inc. (PFE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
43.79-0.46 (-1.04%)
At close: 04:03PM EST
43.88 +0.09 (+0.21%)
After hours: 07:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 3-16.89%
S&P500 52-week change 3-9.85%
52-week high 356.32
52-week low 341.45
50-day moving average 349.32
200-day moving average 348.82

Share statistics

Avg vol (3-month) 321.66M
Avg vol (10-day) 325.51M
Shares outstanding 55.61B
Implied shares outstanding 6N/A
Float 85.61B
% held by insiders 10.05%
% held by institutions 170.42%
Shares short (12 Jan 2023) 437.17M
Short ratio (12 Jan 2023) 41.72
Short % of float (12 Jan 2023) 40.66%
Short % of shares outstanding (12 Jan 2023) 40.66%
Shares short (prior month 14 Dec 2022) 458.02M

Dividends & splits

Forward annual dividend rate 41.64
Forward annual dividend yield 43.75%
Trailing annual dividend rate 31.59
Trailing annual dividend yield 33.59%
5-year average dividend yield 43.58
Payout ratio 430.46%
Dividend date 302 Mar 2023
Ex-dividend date 425 Jan 2023
Last split factor 21054:1000
Last split date 316 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)01 Oct 2022


Profit margin 29.81%
Operating margin (ttm)39.96%

Management effectiveness

Return on assets (ttm)13.32%
Return on equity (ttm)35.51%

Income statement

Revenue (ttm)99.88B
Revenue per share (ttm)17.81
Quarterly revenue growth (yoy)-5.80%
Gross profit (ttm)50.63B
Net income avi to common (ttm)29.95B
Diluted EPS (ttm)5.22
Quarterly earnings growth (yoy)5.70%

Balance sheet

Total cash (mrq)36.13B
Total cash per share (mrq)6.44
Total debt (mrq)37B
Total debt/equity (mrq)39.83
Current ratio (mrq)1.59
Book value per share (mrq)16.51

Cash flow statement

Operating cash flow (ttm)26.6B
Levered free cash flow (ttm)22.83B